OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
David M. Williams, Barbara-Alex Alberts, Asem Sharaf, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 7, pp. 1639-1646
Open Access | Times Cited: 9

Showing 9 citing articles:

The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK
Mohamed Elnaggar, J Mansinho, Samuel J. P. Malkin, et al.
Diabetes Therapy (2025)
Open Access

Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real‐world retrospective study
Silvana Costa, Cesare Miranda, Antonia Elefante, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
Robert F. Kushner, Odd Erik Johansen, Krysmarú Araujo Torres, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 29-29
Open Access

GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
Pernille Holmager, Merete B. Christensen, Kirsten Nørgaard, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 1

Oral semaglutide improves glycemic control and lowers blood lipids: evidence from a real-world study
Dora Gašparini, Fabijan Čakanić, Tomislav Tufekčić, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 4
Open Access

Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
Walter Baronti, Cristina Lencioni, Margherita Occhipinti, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111928-111928
Closed Access

Page 1

Scroll to top